Abbott Laboratories (ABT) revenue

Revenue · fiscal 2025
$44.33B

Abbott Laboratories (ABT) reported revenue of $44.33B in fiscal 2025 (the year ended December 31, 2025). That is 5.7% higher than the $41.95B of fiscal 2024. Figures as of 18 Nov 2026, 10:38 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$44.33B
Change on fiscal 2024
+5.7%
Growth, 5 years
+5.1% a year
Growth, 10 years
+8.1% a year
Highest on record
$44.33Bfiscal 2025
Lowest on record
$19.05Bfiscal 2012
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Abbott Laboratories revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 5.1% a year; over ten years the rate was 8.1% a year. Across the 19 fiscal years on record (2007–2025), the highest was $44.33B in fiscal 2025 and the lowest $19.05B in fiscal 2012.

History · 19 fiscal years

Revenue by fiscal year

Abbott Laboratories revenue, year by year

Abbott Laboratories (ABT) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$44.33B 5.7% up
2024$41.95B 4.6% up
2023$40.11B 8.1% down
2022$43.65B 1.3% up
2021$43.08B 24.5% up
2020$34.61B 8.5% up
2019$31.90B 4.3% up
2018$30.58B 11.6% up
2017$27.39B 31.3% up
2016$20.85B 2.2% up
2015$20.41B 0.8% up
2014$20.25B 3.0% up
2013$19.66B 3.2% up
2012$19.05B 11.0% down
2011$21.41B 39.1% down
2010$35.17B 14.3% up
2009$30.76B 4.2% up
2008$29.53B 13.9% up
2007$25.91B—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

Revenue at health care companies of similar size

Revenue of Abbott Laboratories and comparable companies
CompanyRevenueFiscal year
Gilead Sciences GILD$29.44B2025
Abbott Laboratories ABT$44.33B2025
Novo Nordisk NVODKK 309.06B2025
Pfizer PFE$62.58B2025
Danaher DHR$24.57B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on ABT

Abbott Laboratories, figure by figure

Abbott Laboratories (ABT) overview: price, valuation and scorecardAll health care companies by market value

Abbott Laboratories revenue: questions and answers

What is Abbott Laboratories's revenue?

Abbott Laboratories (ABT) reported revenue of $44.33B in fiscal 2025 (the year ended December 31, 2025). That is 5.7% higher than the $41.95B of fiscal 2024.

What is the growth rate of Abbott Laboratories's revenue?

Over the five fiscal years to 2025 revenue grew at a compound 5.1% a year; over ten years the rate was 8.1% a year.

What are the highest and lowest revenue figures on record for Abbott Laboratories?

Across the 19 fiscal years on record (2007–2025), the highest was $44.33B in fiscal 2025 and the lowest $19.05B in fiscal 2012.

How is Abbott Laboratories's revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Abbott Laboratories it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Abbott Laboratories (ABT) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/ABT/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.